Docturnal

Pre-Seed
docturnal.com Biotech & Healthcare Austin, United States
Total Funding Undisclosed
Latest Round Undisclosed Pre-Seed
Last Announced Aug 10, 2026
Investors Undisclosed
Decision Makers 3 Verified

About Docturnal

Docturnal is a startup developing TimBre, a real-time, non-invasive respiratory disease screening solution using cough acoustic analysis.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Pre-Seed
Global Headquarters Austin, United States
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website docturnal.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Pre-Seed announced

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Docturnal.

Funding History

1 Round
Pre-Seed · Aug 10, 2026
Undisclosed

Founders & Leadership

2

Balakrishna Bagadi

Co-founder, CTO

Work email & phone locked Unlock →

Rahul Pathri

Founder, CEO

Work email & phone locked Unlock →

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts